
Teldawn-Trio 40mg/10mg/12.5mg Tablet
Marketer
Fusion Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Teldawn-Trio 40mg/10mg/12.5mg Tablet
Tri-Med HT 40mg/10mg/12.5mg tablets combine three medications to manage hypertension when single-drug therapy proves insufficient. This formulation effectively reduces elevated blood pressure, mitigating the risk of future strokes and heart attacks. Take Tri-Med HT 40mg/10mg/12.5mg tablets with food, following your doctor's prescribed dosage. Maintain consistent daily timing. Continuous use, as directed by your physician, is crucial. The diuretic component may increase urination; therefore, avoid nighttime doses within four hours of bedtime. Consistent use, even during symptom-free periods, optimizes therapeutic benefit. Discontinuing treatment elevates stroke and heart attack risk. Common side effects include edema (ankle swelling), headache, dizziness, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to counter potential dehydration symptoms such as muscle weakness, dry mouth, and excessive thirst. Inform your doctor about pre-existing kidney or liver conditions before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Always disclose all medications, particularly those for hypertension or heart conditions, to your doctor. Regular monitoring of blood pressure, kidney function, electrolytes, and blood sugar levels is essential to ensure treatment efficacy.
Primary Ingredients of Teldawn-Trio 40mg/10mg/12.5mg Tablet
No text provided. Please provide the text you wish me to rewrite.
Uses of Teldawn-Trio 40mg/10mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Teldawn-Trio 40mg/10mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Teldawn-Trio 40mg/10mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Teldawn-Trio 40mg/10mg/12.5mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Teldawn-Trio 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Teldawn-Trio 40mg/10mg/12.5mg tablets should be administered with a meal.
How Teldawn-Trio 40mg/10mg/12.5mg Tablet works:
Teldawn-Trio tablets (40mg/10mg/12.5mg) combine telmisartan, cilnidipine, and chlorthalidone to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, lowers blood pressure by increasing sodium and water excretion, contributing to reduced vascular resistance.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Teldawn-Trio 40mg/10mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Teldawn-Trio 40mg/10mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Teldawn-Trio 40mg/10mg/12.5mg tablets while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking Teldawn-Trio 40mg/10mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Teldawn-Trio 40mg/10mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised; in fact, use in such patients is generally discouraged.
LiverCAUTION
Individuals with liver impairment should use Teldawn-Trio 40mg/10mg/12.5mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised. Teldawn-Trio 40mg/10mg/12.5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Teldawn-Trio 40mg/10mg/12.5mg Tablet :
Should you forget a Teldawn-Trio 40mg/10mg/12.5mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Teldawn-Trio 40mg/10mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
